Krishnan Viswanadhan, Pharm.D

Krishnan Viswanadhan, Pharm.D

Chief Corporate Development & Strategy OfficeratAgios Pharmaceuticals· In proxies 2023–2025

Pay in FY2025Agios Pharmaceuticals stock -17.2% the same year

Krishnan Viswanadhan, Pharm.D was paid $2.8M in FY2025 (Dec). Agios Pharmaceuticals stock fell 17.2% that year.

Pay$100 in the stock at the end of FY22 → $97
Pay is from the Summary Compensation Table of each Agios Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Agios PharmaceuticalsPublic company · 3 yr
    • Chief Corporate Development & Strategy Officer2023 – Present · 3 yrStock in role +43%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?